Prognostic value of early sustained ventricular arrhythmias in ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: A substudy of VALIDATE-SWEDEHEART trial
Marina M. Demidova(Lund University), Pyotr G. Platonov(Lund University), Kristina Hambræus(Falun Hospital), Loghman Henareh(Karolinska University Hospital), Christian Dworeck, Eva Swahn(Linköping University), Mehmet Hamid(Karolinska University Hospital), Jason Stewart(Örebro University Hospital), Rikard Linder(Karolinska University Hospital), Ole Fröbert(Aarhus University), Rebecca Rylance(Lund University), Stefan James(Uppsala University), David Erlinge(Lund University), Mikael Danielewicz(Örebro University Hospital), Per Grimfjärd(Uppsala University Hospital), Jonas Andersson(Skellefteå Hospital), Henrik Wagner(Örebro University Hospital), Sasha Koul(Lund University), Mikael Aasa(Stockholm South General Hospital)
Cited by 7
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k